FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318447285> ?p ?o ?g. }

• W4318447285 endingPage "100689" @default.
• W4318447285 startingPage "100689" @default.
• W4318447285 abstract "Transcatheter arterial chemoembolisation (TACE) is recommended for patients with hepatocellular carcinoma devoid of macrovascular invasion or extrahepatic spread but not eligible for curative therapies. We compared the efficacy and safety of the combination of a single TACE and external conformal radiotherapy (CRT) vs. classical TACE.TACERTE was an open-labelled, randomised controlled trial with a 1:1 allocation rate to two or three TACE (arm A) or one TACE + CRT (arm B). Participants had a mean age of 70 years, and 86% were male. The aetiology was alcohol in 85%. The primary endpoint was liver progression-free survival (PFS) in the intention-to-treat population. The typical CRT schedule was 54 Gy in 18 sessions of 3 Gy.Of the 120 participants randomised, 64 were in arm A and 56 in arm B; 100 participants underwent the planned schedule and defined the 'per-protocol' group. In intention-to-treat participants, the liver PFS at 12 and 18 months were 59% and 19% in arm A and 61% and 36% in arm B (hazard ratio [HR] 0.69; 95% CI 0.40-1.18; p = 0.17), respectively. In the per-protocol population, treated liver PFS tended to be better in arm B (HR 0.61; 95% CI 0.34-1.06; p = 0.081) than in arm A. Liver-related grade III-IV adverse events were more frequent in arm B than in arm A. Median overall survival reached 30 months (95% CI 23-35) in arm A and 22 months (95% CI 15.7-26.2) in arm B.Although TACE + CRT tended to improve local control, this first Western randomised controlled trial showed that the combined strategy failed to increase PFS or overall survival and led more frequently to liver-related adverse effects.Hepatocellular carcinoma is frequently treated by arterial embolisation of the tumour and more recently by external radiotherapy. We tried to determine whether combination of the two treatments (irradiation after embolisation) might produce interesting results. Our results in this prospective randomised study were not able to demonstrate a beneficial effect of combining embolisation and irradiation in these patients. On the contrary, we observed more adverse effects with the combined treatment.NCT01300143." @default.
• W4318447285 created "2023-01-30" @default.
• W4318447285 creator A5001022411 @default.
• W4318447285 creator A5006848714 @default.
• W4318447285 creator A5007684263 @default.
• W4318447285 creator A5009369449 @default.
• W4318447285 creator A5009433246 @default.
• W4318447285 creator A5011017623 @default.
• W4318447285 creator A5013589390 @default.
• W4318447285 creator A5021485424 @default.
• W4318447285 creator A5022986634 @default.
• W4318447285 creator A5024606671 @default.
• W4318447285 creator A5034759860 @default.
• W4318447285 creator A5052373896 @default.
• W4318447285 creator A5059649023 @default.
• W4318447285 creator A5061984831 @default.
• W4318447285 creator A5068267803 @default.
• W4318447285 creator A5069522018 @default.
• W4318447285 creator A5069539916 @default.
• W4318447285 creator A5075393352 @default.
• W4318447285 creator A5078431055 @default.
• W4318447285 creator A5080007807 @default.
• W4318447285 creator A5084534217 @default.
• W4318447285 creator A5086116904 @default.
• W4318447285 creator A5086517588 @default.
• W4318447285 creator A5087810948 @default.
• W4318447285 creator A5091772447 @default.
• W4318447285 date "2023-04-01" @default.
• W4318447285 modified "2023-10-18" @default.
• W4318447285 title "TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial" @default.
• W4318447285 cites W1535977601 @default.
• W4318447285 cites W2079586464 @default.
• W4318447285 cites W2101181406 @default.
• W4318447285 cites W2147172608 @default.
• W4318447285 cites W2183565736 @default.
• W4318447285 cites W2277004004 @default.
• W4318447285 cites W2560766580 @default.
• W4318447285 cites W2753913404 @default.
• W4318447285 cites W2765356289 @default.
• W4318447285 cites W2917318372 @default.
• W4318447285 cites W2942250106 @default.
• W4318447285 cites W2968989098 @default.
• W4318447285 cites W3004222053 @default.
• W4318447285 cites W3169705253 @default.
• W4318447285 doi "https://doi.org/10.1016/j.jhepr.2023.100689" @default.
• W4318447285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36937990" @default.
• W4318447285 hasPublicationYear "2023" @default.
• W4318447285 type Work @default.
• W4318447285 citedByCount "0" @default.
• W4318447285 crossrefType "journal-article" @default.
• W4318447285 hasAuthorship W4318447285A5001022411 @default.
• W4318447285 hasAuthorship W4318447285A5006848714 @default.
• W4318447285 hasAuthorship W4318447285A5007684263 @default.
• W4318447285 hasAuthorship W4318447285A5009369449 @default.
• W4318447285 hasAuthorship W4318447285A5009433246 @default.
• W4318447285 hasAuthorship W4318447285A5011017623 @default.
• W4318447285 hasAuthorship W4318447285A5013589390 @default.
• W4318447285 hasAuthorship W4318447285A5021485424 @default.
• W4318447285 hasAuthorship W4318447285A5022986634 @default.
• W4318447285 hasAuthorship W4318447285A5024606671 @default.
• W4318447285 hasAuthorship W4318447285A5034759860 @default.
• W4318447285 hasAuthorship W4318447285A5052373896 @default.
• W4318447285 hasAuthorship W4318447285A5059649023 @default.
• W4318447285 hasAuthorship W4318447285A5061984831 @default.
• W4318447285 hasAuthorship W4318447285A5068267803 @default.
• W4318447285 hasAuthorship W4318447285A5069522018 @default.
• W4318447285 hasAuthorship W4318447285A5069539916 @default.
• W4318447285 hasAuthorship W4318447285A5075393352 @default.
• W4318447285 hasAuthorship W4318447285A5078431055 @default.
• W4318447285 hasAuthorship W4318447285A5080007807 @default.
• W4318447285 hasAuthorship W4318447285A5084534217 @default.
• W4318447285 hasAuthorship W4318447285A5086116904 @default.
• W4318447285 hasAuthorship W4318447285A5086517588 @default.
• W4318447285 hasAuthorship W4318447285A5087810948 @default.
• W4318447285 hasAuthorship W4318447285A5091772447 @default.
• W4318447285 hasBestOaLocation W43184472851 @default.
• W4318447285 hasConcept C126322002 @default.
• W4318447285 hasConcept C126894567 @default.
• W4318447285 hasConcept C141071460 @default.
• W4318447285 hasConcept C168563851 @default.
• W4318447285 hasConcept C197934379 @default.
• W4318447285 hasConcept C203092338 @default.
• W4318447285 hasConcept C207103383 @default.
• W4318447285 hasConcept C2778019345 @default.
• W4318447285 hasConcept C2778455285 @default.
• W4318447285 hasConcept C2908647359 @default.
• W4318447285 hasConcept C44249647 @default.
• W4318447285 hasConcept C509974204 @default.
• W4318447285 hasConcept C71924100 @default.
• W4318447285 hasConcept C90924648 @default.
• W4318447285 hasConcept C99454951 @default.
• W4318447285 hasConceptScore W4318447285C126322002 @default.
• W4318447285 hasConceptScore W4318447285C126894567 @default.
• W4318447285 hasConceptScore W4318447285C141071460 @default.
• W4318447285 hasConceptScore W4318447285C168563851 @default.
• W4318447285 hasConceptScore W4318447285C197934379 @default.
• W4318447285 hasConceptScore W4318447285C203092338 @default.
• W4318447285 hasConceptScore W4318447285C207103383 @default.

• next